Syntax Research’s Alimera Sciences ALIM Stock Holding History

Syntax Research’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-80	Closed	-$445	–	201
2024 Q2	$445	Hold	80	–	–	﹤0.01%	173
2024 Q1	$312	Hold	80	–	–	﹤0.01%	169
2023 Q4	$346	Hold	80	–	–	﹤0.01%	174
2023 Q3	$248	Buy	+80	New	+$264	﹤0.01%	177

Syntax Research's ALIM Position: Q3 2024 in Review

Syntax Research sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 80 shares — an estimated $445 sold.

Syntax Research first reported a position in ALIM in Q3 2023 and held it in 4 quarters. The position peaked at $445 in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Syntax Research reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Syntax Research sold 80 Alimera Sciences shares in Q3 2024, an estimated $445.
Syntax Research first reported a position in Alimera Sciences in Q3 2023 and held it in 4 quarters.
Syntax Research's Alimera Sciences position peaked at $445 in Q2 2024.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Syntax Research's 13F filing for Q3 2024, filed 18 Dec 2024.